Navigation Links
Mendel Biotechnology to sell its subsidiary, Mendel Plant Sciences
Date:9/4/2013

HAYWARD, Calif., Sept. 4, 2013 /PRNewswire/ -- Mendel Biotechnology Inc. ("MBI"), a leading agricultural discovery company, is announcing its intention to sell its operating subsidiary, Mendel Plant Sciences ("Mendel" or "the Company"). Mendel Biotechnology Inc. will continue to operate its royalty-based, biotech trait business developed primarily in collaboration with Monsanto. The separation of the two distinct businesses will enable each to maximize their respective value.

Mendel's knowledge of the 'Plant Gene Regulatory Networks', that control crop productivity processes, is a direct result of more than $100 million invested in research and development. This investment in people and facilities has generated advanced technologies, including Mendel's Productivity Reporter Panel, a proprietary screening system, new biotech traits and novel herbicide candidates.  Mendel has discovered performance chemistries and biostimulants that enhance crop productivity through improved drought tolerance, water use, disease resistance and photosynthesis. 

Neal Gutterson, President and CEO of MBI, said: "We have made tremendous progress at Mendel, generating new technologies for improving plant growth and performance through both seed and agrochemical products. We believe that our technologies can help shape the future of the agricultural industry".

MBI has engaged Kirchner Group, a leading mid-market M&A firm with expertise in the agriculture and food industries, to advise the Board and lead the acquisition process.  "The Board of Directors feels that the Company can best achieve its full potential within the context of a larger organization that has a complementary strategic focus.  In this way, it could fully realize its commercial opportunities within the billion-dollar markets that its platform creates," explained Gutterson. Interested parties should contact
'/>"/>

SOURCE Mendel Biotechnology Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. DuPont Pioneer and Mendel Biotechnology, Inc. Collaborate to Improve Water Use Efficiency and Photosynthesis in Corn
2. Quantason Names Dr. Ellen B. Mendelson, Medical Director
3. Commercial Biotechnology Separation Systems Market Analyzed in New Research Report at ReportsnReports.com
4. The Zacks Analyst Blog Highlights: SPDR Health Care Select Sector Fund, SPDR S&P 500, SPDRS&P Biotech ETF, PowerShares S&P SmallCap Health Care Portfolio and PowerShares Dynamic Biotechnology & Genome Portfolio
5. Public Offerings of Common Stock, Financial Results, and Significant Progress in Key Development Programs - Research Report on BioCryst, Exelixis, Idenix, Puma Biotechnology, and Halozyme
6. Sanguine BioSciences Announces Distribution Partnership with AMS Biotechnology
7. Biotech & BioPharma Professionals: CA Board of Pharmacy Executive, Virginia Herold, to Deliver Keynote at BSMA Annual Biotechnology Conference Oct 8-9
8. Biotechnology (BSMA) Conference For Supply Chain Professionals Returns To Foster City, October 8-9, 2013
9. Plant Biotechnology Companies Begin New Conversation about GMOs and How our Food is Grown
10. Nobel Laureate Dr. Oliver Smithies to Deliver Plenary Session at ISPE Biotechnology Symposium
11. TriMix for Travel Now Available at KRS Global Biotechnology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/13/2014)... and TAICHUNG, Taiwan (PRWEB) December 12, 2014 ... less rosy indicators in overall global economic growth, Eugene ... optics and photonics , said in a featured talk ... on 5 December at the National Chung Hsing University ... which is being integrated into future energy supplies and ...
(Date:12/13/2014)... Charlotte, NC (PRWEB) December 13, 2014 ... nearly 3 million people between now and 2030." If ... will become the seventh most populous state in the ... Commerce is gathering at the Future of North Carolina ... We Ready? Do we have the necessary infrastructure in ...
(Date:12/13/2014)... -- Vermillion, Inc. (NasdaqCM: VRML), a bio-analytical solutions company focused on ... G. H. Jordan , Ph.D., and David R. ... the total number of directors to eight, seven of ... , Chairman, President, and Chief Executive Officer of Vermillion, ... of Veronica and David to our board of directors.  ...
(Date:12/13/2014)... , Dec. 12, 2014  Vaccinex ... the discovery and development of therapeutic monoclonal ... today announced publication of a manuscript entitled ... inhibits remyelination in neurodegenerative disease" in the ... of Disease*.  The publication highlights an important ...
Breaking Biology Technology:Photonics Continues Upward Trends Despite Challenges in the Global Economy, Notes SPIE CEO 2Photonics Continues Upward Trends Despite Challenges in the Global Economy, Notes SPIE CEO 3Photonics Continues Upward Trends Despite Challenges in the Global Economy, Notes SPIE CEO 4Photonics Continues Upward Trends Despite Challenges in the Global Economy, Notes SPIE CEO 5North Carolina Chamber of Commerce: Asking Questions & Gathering Answers with a Futurist 2Vermillion Strengthens Board of Directors with Appointments of Veronica Jordan, Ph.D., and David Schreiber 2Vermillion Strengthens Board of Directors with Appointments of Veronica Jordan, Ph.D., and David Schreiber 3Vaccinex announces publication of preclinical studies with an anti-SEMA4D antibody in animal models of neuroinflammatory and demyelinating disease 2
... VRUS ) management will present at the Morgan ... 2008 to May 2,2008 at the Ritz-Carlton Key Biscayne ... provide an overview of the,company and participate in a ... 2008 at 3:40 PM (ET) in the Plaza,Ballroom., ...
... AANS/CNS Section on Tumors,and BrainLAB today announced the ... MD, from the People,s Republic of China, was,awarded ... Bone Marrow,Derived Mesenchymal Stem Cells in Brain Tumor ... a $50,000 stipend to conduct research in his,proposed ...
... 24 The Board of,Directors of Shire plc ... specialty,biopharmaceutical company, announces today that Michael Rosenblatt M.D.,will ... immediate effect., Dr Rosenblatt is the Dean ... was previously Professor of Medicine at Harvard,Medical School ...
Cached Biology Technology:Pharmasset to Present at the Morgan Stanley Global Healthcare Conference on Wednesday, April 30th 2AANS/CNS and BrainLAB Announce Winner of 2008 International Research Fellowship 2AANS/CNS and BrainLAB Announce Winner of 2008 International Research Fellowship 3Dr Michael Rosenblatt Appointed Non-Executive Director at Shire 2Dr Michael Rosenblatt Appointed Non-Executive Director at Shire 3Dr Michael Rosenblatt Appointed Non-Executive Director at Shire 4
(Date:12/17/2014)... Va. , Dec. 15, 2014 ... to make it easier to detect and prevent ... Today the agency started performing an ... capability will validate the authenticity of purchased microcircuits ... The new quality control measures will be conducted ...
(Date:12/17/2014)... , Dec. 16, 2014 Research and Markets ... addition of the "Global Chemical Sensor Market ... http://photos.prnewswire.com/prnh/20130307/600769 One ... increasing demand for medical sensors in biomedical applications. ... for quick and correct diagnosis during surgical procedures. ...
(Date:12/11/2014)... DUBLIN , Dec. 09, 2014 Research ... http://photos.prnewswire.com/prnh/20130307/600769 ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) ... Market in the APAC Region 2015-2019"  report to ... emerging in this market is advances in technology. ... to upgrade biometric solutions to the latest standard ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... Rice University,s Andrew Barron and his group, working with labs ... could block the means by which the deadly virus spreads ... Using computer simulations, researchers tested more than 100 ... other purposes to see if they could be used to ...
... 2009 A unique electrode developed for non-invasive use ... showing promising results in helping to interpret brain signals ... is also being studied as a means of delivering ... conventional disk-shaped electrode, the bulls-eye electrode is made up ...
... In research that could lead to new asthma drugs, ... Massachusetts, and the University of California, San Francisco have discovered ... in mice. They also demonstrated how a drug known to ... in mice. Their paper is published in the May 18-22 ...
Cached Biology News:International team tracks clues to HIV 2International team tracks clues to HIV 3Bull's-eye electrode helps interpret thoughts, deliver stimulus to aid paralyzed, epileptic patients 2Yale team identifies key to potential new treatment for allergy-induced asthma 2